Trial Summary
What is the purpose of this trial?The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites
Eligibility Criteria
This trial is for healthcare providers and practices within Federally Qualified Health Centers aiming to improve HPV vaccination rates among Latino/a adolescents. Specific eligibility criteria are not detailed, but the focus is on provider behavior and practice-level strategies.Inclusion Criteria
Total adolescent patient population at least 50% Latino
I am over 18 and work at a health center as part of the vaccine team.
My practice has an HPV vaccine initiation rate below 60% for 11-12 year olds.
+5 more
Exclusion Criteria
FQHCs that participated in the pilot study were excluded
Participant Groups
The study tests if facilitator-driven strategies at both provider and practice levels can boost recommendations for HPV vaccinations and actual vaccination rates in nine different clinical sites.
3Treatment groups
Experimental Treatment
Group I: Step 3 (3 clinics)-27 months control then 18 months interventionExperimental Treatment1 Intervention
Group II: Step 2 (3 clinics)-21 months control then 24 months interventionExperimental Treatment1 Intervention
Group III: Step 1 (3 clinics)-15 months control then 30 months interventionExperimental Treatment1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
The University of Texas Health Science Center at HoustonHouston, TX
Loading ...
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, HoustonLead Sponsor
National Cancer Institute (NCI)Collaborator